Search results
NeuroOne gains new CMS code for brain ablation system By Investing.com
Investing.com· 2 days agoThe new code, 00503Z4, will be effective from October 1, 2024, and is designated for the destruction...
Tattoo Removal: Everything You Need to Know
Verywell Health via Yahoo News· 13 hours agoIn fact, about 1 in 4 people with a tattoo regret it. If you are in that group, you may wish to look into laser tattoo removal and other options. Lasers...
Autonomix shares positive data from transvascular RF ablation trial
Medical Device Network via Yahoo Finance· 3 days agoTexas-based device company Autonomix Medical has announced preliminary positive results from the...
PFA devices are changing AFib treatment. The next wave could grow the market further.
MedTech Dive via Yahoo Finance· 5 days agoNew pulsed field ablation systems from Boston Scientific and Medtronic are already reshaping the...
Liver Resection Improves Survival in Early Multinodular HCC
Medscape· 1 day agoA large analysis demonstrated longer 3- and 5-year survival rates in patients with early multinodular HCC who underwent liver resection vs nonsurgical alternatives.
AtriCure (ATRC) Stock Slipped on Competition Threat
Insider Monkey via Yahoo Finance· 1 day agoTimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor...
Mediterranean Diet Lowers Tachyarrhythmia in Paroxysmal AF
Medscape· 5 days agoA Mediterranean diet with extra virgin olive oil (EVOO) significantly reduced the risk for...
Venus Concept's (VERO) Latest Supply Deal to Aid its Business
Zacks via Yahoo Finance· 3 days agoMore on Venus Viva Venus Viva is a highly customized skin-resurfacing tool that requires little...
Catheter Precision, Inc. Announces Receipt of First Purchase Order for VIVO from Distributor in...
Digital Journal· 2 days ago"VIVO is a tool that allows physicians to streamline ventricular ablation procedures potentially saving time and reducing patient complications", said Fatih Ayoglu, European ...
The Swiftly Evolving Story of EGFR-Mutated NSCLC Management
MedPage Today· 18 hours agoFor patients with non-small lung cancer (NSCLC), the ADAURA, FLAURA and MARIPOSA trials bestowed...
